Sangeeta Anand PhD

Sangeetha Anand, Ph.D. leads the Benefit-Risk Medical activities for Ferric Carboxymaltose and Vamifeport at CSL Vifor. She also helps manage medical communications and awareness around the relevance of nanomedicines to internal and external stakeholders. She is experienced in medical education and medical communication specializing in Hematology, Women’s Health, and Reproductive Medicine. Her doctoral thesis is in Molecular and Cell Biology from the University of Bern, Switzerland.